Danaher

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Danaher 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. 

CEO
Rainer M. Blair
CEORainer M. Blair
Employees
60,000
Employees60,000
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
1984
Founded1984
Employees
60,000
Employees60,000

DHR Key Statistics

Market cap
142.76B
Market cap142.76B
Price-Earnings ratio
40.57
Price-Earnings ratio40.57
Dividend yield
0.63%
Dividend yield0.63%
Average volume
3.65M
Average volume3.65M
High today
$204.71
High today$204.71
Low today
$199.72
Low today$199.72
Open price
$202.11
Open price$202.11
Volume
4.77M
Volume4.77M
52 Week high
$242.80
52 Week high$242.80
52 Week low
$171.00
52 Week low$171.00

Stock Snapshot

As of today, Danaher(DHR) shares are valued at $201.75. The company's market cap stands at 142.76B, with a P/E ratio of 40.57 and a dividend yield of 62.5%.

As of 2026-03-05, Danaher(DHR) stock has fluctuated between $199.72 and $204.71. The current price stands at $201.75, placing the stock +1.0% above today's low and -1.4% off the high.

Danaher(DHR) shares are trading with a volume of 4.77M, against a daily average of 3.65M.

In the last year, Danaher(DHR) shares hit a 52-week high of $242.80 and a 52-week low of $171.00.

In the last year, Danaher(DHR) shares hit a 52-week high of $242.80 and a 52-week low of $171.00.

DHR News

Simply Wall St 6d
Danaher’s US$9.9b Masimo Deal Refocuses Growth On Diagnostics Valuation

Danaher (NYSE:DHR) has agreed to acquire Masimo Corporation in a cash and stock deal valued at $9.9b. Masimo, a specialty diagnostics leader, will operate as a...

Danaher’s US$9.9b Masimo Deal Refocuses Growth On Diagnostics Valuation

Analyst ratings

85%

of 27 ratings
Buy
85.2%
Hold
14.8%
Sell
0%

People also own

Based on the portfolios of people who own DHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.